NatalizumabDevelopment of anti-drug antibodies and treatment failure: 6 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1897卷 / 1期
关键词：
D O I：
10.1007/s40278-022-11523-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：286 / 286
相关论文
共 50 条
  • [21] ANTI-DRUG ANTIBODIES TO INFLIXIMAB: A COMPARISON OF FREE ANTI-DRUG ANTIBODY MEASUREMENT
    Hamilton, Rhona
    Shields, Stephanie
    Macdonald, Jonathan
    Dunlop, Allan
    Perry, Martin
    McGucken, Andrew
    Gribben, Elain
    Galloway, Peter
    GUT, 2021, 70 : A121 - A121
  • [22] AdalimumabDevelopment of anti-drug antibodies and no therapeutic response: case report
    Reactions Weekly, 2023, 1943 (1) : 21 - 21
  • [23] The case for measuring anti-drug antibodies in people with multiple sclerosis
    Ryner, Malin Lundkvist
    Farrell, Rachel A.
    Fogdell-Hahn, Anna
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (06) : 697 - 699
  • [24] Methotrexate BAFFles anti-drug antibodies
    Cronstein, Bruce N.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (09) : 505 - 506
  • [25] Methotrexate BAFFles anti-drug antibodies
    Bruce N. Cronstein
    Nature Reviews Rheumatology, 2018, 14 : 505 - 506
  • [26] Anti-Drug Antibodies Detected By Competitive ELISA Can Predict Treatment Failure in Patients Taking Adalimumab
    Ogric, Manca
    Zigon, Polona
    Lakota, Katja
    Praprotnik, Sonja
    Drobne, David
    Stabuc, Borut
    Semrl, Snezna Sodin
    Cucnik, Sasa
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] Adalimumab/methotrexateLack of efficacy and development of anti-drug antibodies : case report
    Reactions Weekly, 2018, 1724 (1) : 18 - 18
  • [28] Adalimumab/etanerceptNeutralising anti-drug antibodies and lack of efficacy: case report
    Reactions Weekly, 2021, 1844 (1) : 19 - 19
  • [29] RituximabSevere infusion reaction and anti-drug antibodies
    Reactions Weekly, 2023, 1985 (1) : 465 - 465
  • [30] Anti-drug antibodies in the current management of cancer
    Miguel Borregón
    Katherine Martínez
    Alba Ramos
    Irene Ramos
    Beatriz Berzal
    Manuel Mazariegos
    Elia Martínez
    Tatiana Hernández
    Bernard Doger
    Víctor Moreno
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 577 - 584
12345